Regramostim (GM-CSF) is a differentially glycosylated factor produced mainly by activated T cells and macrophages. Endothelial cells and fibroblasts can also produce GM-CSF after exposure to TNF-α, IL-1, IL-2 and IFN-γ. GM-CSF is found associated with extracellular matrix and in membrane-bound formats too. GM-CSF stimulates proliferation, activation and diff...
Investigated for use/treatment in adverse effects (chemotherapy) and bone marrow transplant.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.